Boston Financial Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $538K | Buy |
9,505
+200
| +2% | +$11.2K | 0.02% | 236 |
|
|
2024
Q3 | $481K | Sell |
9,305
-4
| -0% | -$188 | 0.01% | 243 |
|
|
2024
Q2 | $387K | Sell |
9,309
-2,725
| -23% | -$122K | 0.01% | 262 |
|
|
2024
Q1 | $653K | Sell |
12,034
-751
| -6% | -$38.3K | 0.02% | 226 |
|
|
2023
Q4 | $656K | Sell |
12,785
-421
| -3% | -$22.1K | 0.02% | 221 |
|
|
2023
Q3 | $766K | Sell |
13,206
-2,321
| -15% | -$142K | 0.03% | 195 |
|
|
2023
Q2 | $993K | Buy |
15,527
+1,319
| +9% | +$88.4K | 0.04% | 184 |
|
|
2023
Q1 | $985K | Sell |
14,208
-1,735
| -11% | -$122K | 0.04% | 175 |
|
|
2022
Q4 | $1.15M | Buy |
15,943
+475
| +3% | +$35.8K | 0.05% | 168 |
|
|
2022
Q3 | $1.1M | Buy |
15,468
+133
| +0.9% | +$9.65K | 0.05% | 163 |
|
|
2022
Q2 | $1.18M | Buy |
15,335
+183
| +1% | +$13.9K | 0.05% | 151 |
|
|
2022
Q1 | $1.11M | Sell |
15,152
-271
| -2% | -$18.2K | 0.04% | 154 |
|
|
2021
Q4 | $962K | Buy |
15,423
+1,296
| +9% | +$76K | 0.04% | 150 |
|
|
2021
Q3 | $836K | Hold |
14,127
| – | – | 0.03% | 147 |
|
|
2021
Q2 | $944K | Hold |
14,127
| – | – | 0.04% | 137 |
|
|
2021
Q1 | $892K | Sell |
14,127
-2,141
| -13% | -$133K | 0.04% | 130 |
|
|
2020
Q4 | $1.01M | Sell |
16,268
-300
| -2% | -$18.4K | 0.05% | 125 |
|
|
2020
Q3 | $999K | Sell |
16,568
-625
| -4% | -$37.6K | 0.05% | 126 |
|
|
2020
Q2 | $1.01M | Sell |
17,193
-1,020
| -6% | -$61K | 0.05% | 122 |
|
|
2020
Q1 | $1.01M | Sell |
18,213
-561
| -3% | -$34.3K | 0.07% | 116 |
|
|
2019
Q4 | $1.21M | Sell |
18,774
-633
| -3% | -$36.3K | 0.07% | 124 |
|
|
2019
Q3 | $984K | Sell |
19,407
-100
| -0.5% | -$4.7K | 0.06% | 136 |
|
|
2019
Q2 | $885K | Sell |
19,507
-2,550
| -12% | -$119K | 0.05% | 142 |
|
|
2019
Q1 | $1.05M | Sell |
22,057
-787
| -3% | -$39.2K | 0.06% | 135 |
|
|
2018
Q4 | $1.19M | Sell |
22,844
-4,132
| -15% | -$222K | 0.08% | 128 |
|
|
2018
Q3 | $1.68M | Buy |
26,976
+5,802
| +27% | +$344K | 0.1% | 133 |
|
|
2018
Q2 | $1.17M | Sell |
21,174
-1,392
| -6% | -$75.2K | 0.08% | 142 |
|
|
2018
Q1 | $1.43M | Sell |
22,566
-758
| -3% | -$48.8K | 0.1% | 143 |
|
|
2017
Q4 | $1.43M | Sell |
23,324
-645
| -3% | -$40.3K | 0.1% | 151 |
|
|
2017
Q3 | $1.53M | Buy |
23,969
+780
| +3% | +$45.5K | 0.11% | 150 |
|
|
2017
Q2 | $1.29M | Sell |
23,189
-143,994
| -86% | -$7.84M | 0.09% | 162 |
|
|
2017
Q1 | $9.09M | Sell |
167,183
-15,115
| -8% | -$829K | 0.68% | 54 |
|
|
2016
Q4 | $10.7M | Sell |
182,298
-4,410
| -2% | -$241K | 0.84% | 35 |
|
|
2016
Q3 | $10.1M | Sell |
186,708
-7,458
| -4% | -$479K | 0.82% | 28 |
|
|
2016
Q2 | $14.3M | Buy |
194,166
+153,326
| +375% | +$10.8M | 1.16% | 18 |
|
|
2016
Q1 | $2.61M | Sell |
40,840
-1,425
| -3% | -$89.9K | 0.39% | 87 |
|
|
2015
Q4 | $2.91M | Sell |
42,265
-2,790
| -6% | -$184K | 0.42% | 84 |
|
|
2015
Q3 | $2.67M | Sell |
45,055
-550
| -1% | -$34.9K | 0.38% | 87 |
|
|
2015
Q2 | $3.04M | Sell |
45,605
-1,725
| -4% | -$114K | 0.39% | 83 |
|
|
2015
Q1 | $3.05M | Buy |
47,330
+300
| +0.6% | +$18.8K | 0.38% | 87 |
|
|
2014
Q4 | $2.78M | Sell |
47,030
-7,990
| -15% | -$451K | 0.35% | 91 |
|
|
2014
Q3 | $2.82M | Sell |
55,020
-1,741
| -3% | -$87K | 0.37% | 87 |
|
|
2014
Q2 | $2.75M | Sell |
56,761
-10
| -0% | -$493 | 0.36% | 82 |
|
|
2014
Q1 | $2.95M | Buy |
56,771
+1,615
| +3% | +$85.9K | 0.39% | 78 |
|
|
2013
Q4 | $2.93M | Buy |
55,156
+1,073
| +2% | +$54.7K | 0.4% | 74 |
|
|
2013
Q3 | $2.5M | Buy |
54,083
+425
| +0.8% | +$18.7K | 0.38% | 77 |
|
|
2013
Q2 | $2.4M | Buy |
+53,658
| New | +$2.33M | 0.37% | 77 |
|
Other funds holding BMY
Boston Financial Management's BMY Position: Q4 2024 in Review
Boston Financial Management increased its Bristol-Myers Squibb (BMY) stake by 2.1% in Q4 2024, buying an estimated $11.2K and bringing the position to 9,505 shares worth $538K. The position accounts for 0.02% of the portfolio, ranked #236.
Boston Financial Management first reported a position in BMY in Q2 2013 and has held it in 47 quarters since. The position peaked at $14.3M in Q2 2016. 2,487 funds tracked by Wall St. Rank hold BMY as of Q4 2024.
- Boston Financial Management held 9,505 shares of Bristol-Myers Squibb worth $538K as of Q4 2024.
- Boston Financial Management bought 200 Bristol-Myers Squibb shares in Q4 2024, an estimated $11.2K.
- Bristol-Myers Squibb made up 0.02% of Boston Financial Management's portfolio in Q4 2024, its #236 holding.
- Boston Financial Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 47 quarters since.
- Boston Financial Management's Bristol-Myers Squibb position peaked at $14.3M in Q2 2016.
- 2,487 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2024.
Based on Boston Financial Management's 13F filing for Q4 2024, filed 3 Feb 2025.